BOOK NOW
BOOK NOW
BOOK DISCOVERY CALL
Menu

Day: September 3, 2024

CJC/Ipamorelin Peptide Therapy

Peptide therapy just got an upgrade with CJC+Ipamoreline therapy. This is a unique combination of the two compounds– CJC1295 and Ipamorelin. Peptide therapies administered usually have one or both of these peptides. CJC is a chemically synthesised peptide that boosts the growth hormone production from the pituitary. On the other hand, Ipamorelin is a pentapeptide… Continue reading CJC/Ipamorelin Peptide Therapy

Richard Morgan Evans

Founder & CEO of Sapience Communications

Richard co-founded Sapience with three highly successful business figures in the UK, including former bank and private equity CEOs. This followed previous careers in law, working as an equity analyst for a number of investment banks and financial journalism, which included writing for The Economist, The Times and The Independent.

During his journalist career, he visited the Gulf and Saudi Arabia many times, interviewing senior banking and business figures, such as the head of the Saudi Central Bank and leaders at Saudi Aramco, SABIC, Olayan Group and the Kanoo Group. A number of his features appeared in the Wall Street Journal, Financial Times and The Washington Post.

His PR experience includes being the MD of the Financial Division of a leading UK multidisciplinary PR consultancy before co-founding Sapience. He is often asked to judge PR awards, most recently he was on the judging panel of the Public Relations Consultancy Association’s Financial Services PR awards.

He specialises in advising on strategic media relations, reputational risk, media relations and training, crisis communications, and all forms of corporate transactions. Richard is a law graduate of the University of Cambridge.

Login

Sign-up

A link to set a new password will be sent to your email address.

Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

+971 55 545 0797

About
Company
Resources